Soy isoflavones, Mediterranean diet, and physical exercise in postmenopausal women with insulin resistance

Menopause

Volumn 17, Issue 2, 2010, Pages 372-378

  Llaneza, Placido ^a   Gonzalez, Celestino ^b   Fernandez Iñarrea, Jose ^c   Alonso, Ana ^b   Diaz Fernandez, Maria J ^d   Arnott, Ignacio ^a   Ferrer Barriendos, Javier ^a  

^a Central University Hospital of Asturias   (Spain)

^b UNIVERSITY OF OVIEDO   (Spain)

^c HOSPITAL DE CABUEÑES   (Spain)

^d Valle del Nalón Hospital   (Spain)

Author keywords

Insulin resistance; Mediterranean diet; Menopause; Physical exercise; Soy isof lavones

Indexed keywords

CHOLESTEROL; CREATININE; CYANOCOBALAMIN; ESTRADIOL; FOLIC ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; INSULIN; ISOFLAVONE DERIVATIVE; LOW DENSITY LIPOPROTEIN; SELENIUM; SOY ISOFLAVONE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; URIC ACID;

ABDOMINAL CIRCUMFERENCE; ADULT; ANTHROPOMETRY; ARTICLE; BLOOD SAMPLING; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ESTRADIOL BLOOD LEVEL; EXERCISE; FEMALE; FOLIC ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LEAN BODY WEIGHT; LIFESTYLE MODIFICATION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MEDITERRANEAN DIET; POSTMENOPAUSE; PRESCRIPTION; SCORING SYSTEM; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; VITAMIN BLOOD LEVEL;

ANTHROPOMETRY; BLOOD GLUCOSE; DIET, MEDITERRANEAN; EXERCISE THERAPY; FEMALE; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; ISOFLAVONES; MIDDLE AGED; MODELS, BIOLOGICAL; POSTMENOPAUSE; SOYBEAN PROTEINS; TREATMENT OUTCOME;

EID: 77949382900     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181ba56fa     Document Type: Article

References (37)

1. Spanish National Statistics Institute. Society. Health. National Health Survey. http://www.ine.es/inebase/cgi/axi. Accessed April 2009.
2. Toth M, Tchernof A, Sites C, Poehlman E. Menopause related changes in body fat distribution. Ann N Y Acad Sci 2000;904:502-506.
3. Donato G, Fuchs S, Oppermann K, Bastos C, Spritzer P. Association between menopause status and central adiposity measured at different cut-offs of waist circumference and waist-to-hip ratio. Menopause 2006;13:280-285.
4. Uauy R, Diaz E. Consequences of food energy excess and positive energy balance. Public Health Nutr 2005;8:1077-1099.
5. Orden C, Yanovski S, Carrol M, Flegal K. The epidemiology of obesity. Gastroenterology 2007;132:2087-2102.
6. Deveci E, Yesil M, Akinci B, et al. Evaluation of insulin resistance in normoglycemic patients with coronary artery disease. Clin Cardiol 2009;32:32-36.
7. Huffman K, Slentz C, Johnson J, et al. Impact of hormone replacement therapy on exercise training-induced improvements in insulin action in sedentary overweight adults. Metabolism 2008;57:888-895.
8. Salpeter S, Walsh J, Ormiston T, Greyber E, Buckley N, Salpeter E. Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes Obes Metab 2006;8:538-554.
9. The European Agency for Evaluation of Medicinal Products. EMEA public statement on recent publications regarding hormone replacement therapy. Available at: http://www.emea.europa.eu/pdfs/human/press/pus/ 3306503en.pdf.
10. Zhang M, Ikeda K, Xu J, Yamori Y, Gao X, Zhang B. Soy isof lavones suppresses adipogenesis of 3T3-L1 cells via multiple signal pathways. Phytother Res 2009;23:713-718.
11. de Kleijn MJ, van der Schouw YT, Wilson PW, Grobbee DE, Jacques PF. Dietary intake of phytoestrogens is associated with a favorable metabolic cardiovascular risk profile in postmenopausal U.S. women: the Framingham Study. J Nutr 2002;132:276-282.
12. Yang JY, Della-Fera MA, Rayalam S, Ambati S, Baile CA. Enhanced pro-apoptotic and anti-adipogenic effects of genistein plus guggulsterone in 3T3-L1 adipocytes. Biofactors 2007;30:159-169.
13. Azadbakht L, Kimiagar M, Mehrabi Y, et al. Soy inclusion in the diet improves features of the metabolic syndrome: a randomized crossover study in postmenopausal women. Am J Clin Nutr 2007;85:735-741.
14. Tempfer C, Bentz E, Leodolter S, et al. Phytoestrogens in clinical practice: a review of the literature. Fertil Steril 2007;87:1243-1249.
15. Atteritano M, Marini H, Minutoli L, et al. Effects of the phytoestro-gen soy isof lavones on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a two-year randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 2007;92: 3068-3075.
16. Hall W, Vafeiadou K, Hallund J, et al. Soy-isof lavoneYenriched foods and markers of lipid and glucose metabolism in postmenopausal women: interactions with genotype and equol production. Am J Clin Nutr 2006; 83:592-600.
17. Penza M, Montani C, Romani A, et al. Genistein affects adipose tissue deposition in a dose-dependent and gender-specific manner. Endocrinology 2006;147:5740-5751.
18. Jou H, Wu S, Chang F, Ling P, Chu K, Wu W. Effect of intestinal production of equol on menopausal symptoms in women treated with soy isof lavones. Int J Gynaecol Obstet 2008;102:44-49.
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and A-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
20. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;365:1415-1428.
21. Palacios S, Ferrer-Barriendos J, Parrilla J, et al. Health-related quality of life in the Spanish women through and beyond menopause. Development and validation of the Cervantes Scale. Med Clin (Barc) 2004;122: 205-211.
22. Jayagopal V, Kilpatrick E, Jennings P, Hepburn D, Atkin S. Biological variation of homeostasis model assessmentVderived insulin resistance in type 2 diabetes. Diabetes Care 2002;25:2022-2025.
23. Cho G, Lee J, Park H, et al. Postmenopausal status according to years since menopause as an independent risk factor for the metabolic syndrome. Menopause 2008;15:524-529.
24. Chiyoko U, Jun O, Jun Y, Yumi S, Mitsuru H. Basic metabolic rates and its determinants in postmenopausal women. Jpn Soc Phys Fitness Sport Med 2003;52:189-198.
25. Ubeda N, Basagoiti M, Alonso-Aperte E, Varela-Moreiras G. Dietary food habits, nutritional status and lifestyle in menopausal women in Spain. Nutr Hosp 2007;22:313-321.
26. Roman B, Carta L, Mart́inez-González MA, Serra-Majem L. Effectiveness of the Mediterranean diet in the elderly. Clin Interv Aging 2008; 3:97-109.
27. Ross R, Janssen I, Dawson J, et al. Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial. Obes Res 2004;12:789-798.
28. Dubnov-Raz G, Pines A, Berry EM. Diet and lifestyle in managing postmenopausal obesity. Climacteric 2007;10(Suppl 2):38-41.
29. Vedavanam K, Srijayanta S, O'Reilly J, Raman A, Wiseman H. An-tioxidant action and potential antidiabetic properties of an isoflavonoid-containing soya bean phytochemical extract (SPE). Phytother Res 1999; 13:601-608.
30. Hisatomi M, Hayakawa T, Hidaka H, Niki I. Modulation of tyro-sine kinase activity has multiple actions on insulin release from the pancreatic A-cell: studies with lavendustin A. Jpn J Pharmacol 1997;74: 203-208.
31. Ricketts ML, Moore DD, Banz WJ, Mezei O, Shay NF. Molecular mechanisms of action of the soy isof lavones includes activation of promiscuous nuclear receptors. A review. J Nutr Biochem 2005;16: 321-330.
32. Lukaczer D, Liska D, Lerman R, et al. Effect of a low glycemic index diet with soy protein and phytosterols on CVD risk factors in post-menopausal women. Nutrition 2006;22:104-113.
33. Crisafulli A, Altavilla D, Marini H, et al. Effects of the phytoestro-gen genistein on cardiovascular risk factors in postmenopausal women. Menopause 2005;12:186-192.
34. Grundy S, Cleeman J, Daniels S, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005;112: 2735-2752.
35. Samat A, Rahim A, Barnett A. Pharmacotherapy for obesity in meno-pausal women. Menopause Int 2008;14:57-62.
36. Basaria S, Wisniewski A, Dupree K, et al. Effect of high-dose iso-flavones on cognition, quality of life, androgens, and lipoprotein in post-menopausal women. J Endocrinol Invest 2009;32:150-155.
37. Llaneza P, González C, Fernandez-Iñarrea J, Alonso A, Arnott I, Ferrer-Barriendos J. Insulin resistance and health-related quality of life in postmenopausal women. Fertil Steril 2009;91:1370-1373.